(1 - 15 from 16
)
AZ nabs US approval for new leukaemia drug Lumoxiti - PMLiVE
www.pmlive.com
... to ten years after their first treatment,” said Robert Kreitman of the National Cancer Institute (NCI) in the US, the lead investigator in the study.
The Sasaki Lab - News - Atsuo T. Sasaki
www.thesasakilab.org
Dr. Robert Kreitman (NCI)'s track record on his Hairy Cell Leukemia impressed all the attendees. Recently his team has uncovered new oncogenic mutations, ...
sorted by relevance / date